pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
bleomycin sulfate
Bleomycin Sulfate (bleomycin sulfate)
Cervical Cancer
Northstar Rx LLC
0 catalysts
Phase 2
bleximenib besylate
Refractory Acute Myeloid Leukemia
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 3
bomedemstat tosylate
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
$MRKMerck & Co., Inc.
0 catalysts
Marketed
← prev
page 42 of 62
next →
131
Pain89
Neurology1
bosutinib
Bosutinib (bosutinib)
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Alembic Pharmaceuticals Inc
0 catalysts
Phase 2
botensilimab
Metastatic Colorectal Cancer
$AGENAGENUS INC
0 catalysts
Phase 2
brexucabtagene autoleucel
Tecartus (brexucabtagene autoleucel)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
B-lymphocyte antigen CD19
$GILDGILEAD SCIENCES, INC.
0 catalysts
Marketed
brigatinib
Alunbrig (brigatinib)
Non-Small Cell Lung Cancer
Takeda Pharmaceuticals USA Inc
0 catalysts
Phase 2
bulumtatug fuvedotin
bulumtatug fuvedotin [INN]
Esophageal Squamous Cell Carcinoma (ESCC)
Mabwell Shanghai Bioscience Co Ltd
0 catalysts
Marketed
cabazitaxel
Jevtana (cabazitaxel)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sanofi-Aventis US LLC
0 catalysts
Phase 2
cabiralizumab
cabiralizumab [INN]
Pigmented Villonodular Synovitis
Bristol-Myers Squibb Co
0 catalysts
pre_registration
cabozantinib
Hepatocellular Carcinoma
Hepatocyte growth factor receptorVascular endothelial growth factor receptor 2
Lotus Pharmaceutical Co Ltd
0 catalysts
Phase 2
cafelkibart
cafelkibart [INN]
Solid Tumor
LaNova Medicines Ltd
0 catalysts
Marketed
calaspargase pegol
Asparlas (calaspargase pegol)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Servier Pharmaceuticals LLC
0 catalysts
Phase 1
calotatug ginistinag
calotatug ginistinag [INN]
Colorectal Cancer
$DAWNDay One Biopharmaceuticals, Inc.
0 catalysts
Phase 2
camonsertib
Solid Tumor
XenoTherapeutics Inc
0 catalysts
Phase 2
camupepimut
Colorectal Cancer
$ELTXElicio Therapeutics, Inc.
0 catalysts
Preclinical
candesartan
Pancreatic Ductal Adenocarcinoma
Hebrew University of Jerusalem
0 catalysts
Phase 2
canerpaturev
Metastatic Melanoma
Takara Bio Inc
0 catalysts
Marketed
capmatinib hydrochloride
Tabrecta (capmatinib hydrochloride)
Non-Small Cell Lung Cancer
$NVSNOVARTIS AG
0 catalysts
Marketed
carfilzomib
Kyprolis (carfilzomib)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
26S proteasome
$AMGNAMGEN INC
0 catalysts
Marketed
carmustine
Carmustine (carmustine)
Astrocytoma
STI Pharma LLC
0 catalysts
Phase 2
carotuximab
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Endoglin
$KAPAKairos Pharma, LTD.
0 catalysts
Phase 2
casdozokitug
Hepatocellular Carcinoma
$CHRSCoherus Oncology, Inc.
0 catalysts
Phase 3
catequentinib hydrochloride
Soft Tissue Sarcoma
Advenchen Laboratories LLC
0 catalysts
Phase 1
cedazuridine + decitabine + tolinapant
cedazuridine + decitabine + tolinapant [INN]
T-Cell Lymphomas
Otsuka Pharmaceutical Co Ltd
0 catalysts
Phase 3
cediranib maleate
Epithelial Ovarian Cancer
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
cemacabtagene ansegedleucel
Primary Mediastinal B-Cell Lymphoma
$ALLOAllogene Therapeutics, Inc.
0 catalysts
Phase 2
cemsidomide
Anaplastic Large Cell Lymphoma (ALCL)
$CCCCC4 Therapeutics, Inc.
0 catalysts
Preclinical
cerium oxide
Radiodermatitis
BioCurity Pharmaceuticals Inc
0 catalysts
Phase 2
certepetide
Bile Duct Cancer (Cholangiocarcinoma)
$LSTALISATA THERAPEUTICS, INC.
0 catalysts